TrialClinical and vaccine immunology : CVI2014

Safety and immunogenicity of tetanus-diphtheria-acellular pertussis vaccine administered to children 10 or 11 years of age.

Gary S Marshall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.